Business Context and Reporting Period
Company: Charles River Laboratories International, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 19, 2025
Reporting Period: Fourth quarter and fiscal year ended December 28, 2024.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. This 8-K serves as a notification that financial results were issued via a press release (Exhibit 99.1) but does not contain the detailed financial data within the body of the report.
Material Changes
No material changes or comparative financial data are detailed in the text of this filing. The document references the attached press release for the full disclosure of results for the fourth quarter and fiscal year ended December 28, 2024.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The referenced press release contains "safe harbor" language under the Private Securities Litigation Reform Act of 1995, indicating the presence of forward-looking statements.
- Risks: The filing states that risks relating to the company are set forth in documents filed with the SEC, rather than listing them explicitly in this report.
- Unusual Items: No unusual items are described in the text of this filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 19, 2025) for actual revenue, earnings, and cash flow figures.
- Verify the specific forward-looking statements and associated risk factors detailed in the press release.
- Confirm the fiscal year-end date of December 28, 2024, for accurate period comparison.
- Check subsequent SEC filings for detailed risk disclosures referenced in this report.